Related references
Note: Only part of the references are listed.Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis
Lieve Van Hoovels et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Evaluation of subclinical gut inflammation using faecal calprotectin levels and colonic mucosal biopsy in patients with psoriasis and psoriatic arthritis
M. B. Adarsh et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate
Ulla Bregendahl Nielsen et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2018)
Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein
Jana Hurnakova et al.
CLINICAL RHEUMATOLOGY (2018)
The non-haemostatic role of platelets in systemic lupus erythematosus
Petrus Linge et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
The role and therapeutic targeting of IL-6 in rheumatoid arthritis
Masashi Narazaki et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Psoriatic Arthritis
Christopher T. Ritchlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial
Nicole P. C. Konijn et al.
RHEUMATOLOGY (2017)
Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-up
Julio Ramirez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis
Maria Karolina Jonsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Fecal calprotectin in inflammatory bowel diseases: update and perspectives
Hana Manceau et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
The effect of smoking on myeloid-related protein-8 and myeloid-related protein-14
Abdullah Seckin Ertugrul et al.
BRAZILIAN ORAL RESEARCH (2016)
EDISON-WMW: Exact Dynamic Programing Solution of the Wilcoxon-Mann-Whitney Test
Alexander Marx et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2016)
Calprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review
Mads Abildtrup et al.
JOURNAL OF RHEUMATOLOGY (2015)
MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis
Ivy Y. Choi et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Intensive combination treatment regimens, including prednisolone, are effective in treating patients with early rheumatoid arthritis regardless of additional etanercept: 1-year results of the COBRA-light open-label, randomised, non-inferiority trial
Marieke M. ter Wee et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Clinical significance of serum interleukin-6 and -174 G/C promoter polymorphism in Rheumatoid arthritis patients
Wafaa Gaber et al.
EGYPTIAN RHEUMATOLOGIST (2013)
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ARTHRITIS AND RHEUMATISM (2011)
The Correlation between Increased Serum Concentrations of Interleukin-6 Family Cytokines and Disease Activity in Rheumatoid Arthritis Patients
Soo-Jin Chung et al.
YONSEI MEDICAL JOURNAL (2011)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Daniel Aletaha et al.
ARTHRITIS AND RHEUMATISM (2010)
Erythrocyte Sedimentation Rate, C-Reactive Protein, or Rheumatoid Factor Are Normal at Presentation in 35%-45% of Patients with Rheumatoid Arthritis Seen Between 1980 and 2004: Analyses from Finland and the United States
Tuulikki Sokka et al.
JOURNAL OF RHEUMATOLOGY (2009)
Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis
J van Aken et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Share Paper
